Drug-resistant tuberculosis
Do you want to receive a message when there is new research on Drug-resistant tuberculosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as new research on Drug-resistant tuberculosis becomes available. View what Premium costs.
Publications and studies (1457)
- Pulmonary tuberculosis and multidrug-resistant Mycobacterium tuberculosis in northwestern Ethiopia: a hospital-based cross-sectional study among presumptive pulmonary tuberculosis patients. (2023/12/12) ♡
- Metagenomic identification of pathogens and antimicrobial-resistant genes in bacterial positive blood cultures by nanopore sequencing. (2023/12/12) ♡
- Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment. (2023/12/11) ♡
- In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA)Inhibitors. (2023/12/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multi-Drug Resistance Tuberculosis (MDR-TB) Challenges in India: A Review. (2023/12/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Revolutionizing Tuberculosis Treatment: Uncovering New Drugs and Breakthrough Inhibitors to Combat Drug-Resistant Mycobacterium tuberculosis. (2023/12/08) ♡
- Adenoviral Vector Codifying for TNF as a Co-Adjuvant Therapy against Multi-Drug-Resistant Tuberculosis. (2023/12/07) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase. (2023/12/05) ♡
- Incidence and predictors of treatment interruption among patients on anti-tuberculosis treatment in Nekemte public healthcare facilities, Oromia, Western Ethiopia. (2023/12/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Antimicrobial Peptides as Immunomodulators and Antimycobacterial Agents to Combat Mycobacterium tuberculosis: a Critical Review. (2023/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dynamics of tuberculosis infection in various populations during the 19th and 20th century: The impact of conservative and pharmaceutical treatments. (2023/12/01) ♡
- Descriptors of multidrug-resistant TB deaths in Ethiopia. (2023/12/01) ♡
- Multidrug-resistant tuberculosis in Colombia, 2013-2018: a case-control study. (2023/12/01) ♡
- Prevalence of isoniazid resistance in cases of rifampicin resistance detected on GeneXpert MTB/RIF assay. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An unusual complication secondary to kanamycin use in a patient of multidrug-resistant pulmonary tuberculosis. (2023/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: An updated systematic review and meta-analysis. (2023/12/01) ♡
- The trial of sending short message service multidrug-resistant tuberculosis patients in Indonesia: the chance to increase knowledge and motivation. (2023/12/01) ♡
- Factors influencing histoplasmosis incidence in multidrug-resistant pulmonary tuberculosis patients: A cross-sectional study in Indonesia. (2023/12/01) ♡
- Profile and risk factors of pre-XDR-TB and XDR-TB patients in a national reference hospital for Sumatra region of Indonesia. (2023/12/01) ♡
- Efficacy of pretomanid-containing regimens for drug-resistant tuberculosis: A systematic review and meta-analysis of clinical trials. (2023/12/01) ♡
- Assessing the Effect of the Anti-tuberculosis Drug Rifampicin on Known Hypertensive Patients With Tuberculosis in a Tertiary Care Center. (2023/11/30) ♡
- Marine-Fungi-Derived Gliotoxin Promotes Autophagy to Suppress Mycobacteria tuberculosis Infection in Macrophage. (2023/11/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. India's Decision to Deny an Extension of Patent for Bedaquiline: A Public Health Imperative. (2023/11/28) ♡
- Influencing factors of death in patients with MDR-TB based on Bayesian Cox regression model. (2023/11/28) ♡
- Assessment of Comorbidity in Patients with Drug-Resistant Tuberculosis. (2023/11/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Symphony of Challenges: Multi-Drug Resistant Tuberculosis, Pleurocutaneous Fistula, and Empyema Necessitans in Concert. (2023/11/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pharmacokinetics and Safety of Group A and B Anti-Tuberculosis Drugs Used in Treatment of Rifampicin-Resistant Tuberculosis during Pregnancy and Post-Partum: A Narrative Review. (2023/11/24) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. (2023/11/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pediatric Drug-Resistant Tuberculosis: The Current and Future Prospects for Management and Prevention. (2023/11/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Ear tuberculosis concomitant with pulmonary localization in an HIV-immunosuppressed patient, in Bamako, Mali]. (2023/11/17) ♡
- [Drug-resistant pulmonary tuberculosis at Maradi Regional Hospital Center, Niger (2014-2018)]. (2023/11/06) ♡
- Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa. (2023/11/06) ♡
- Management of drug-resistant tuberculosis in Indonesia: a four-year cascade of care analysis. (2023/11/02) ♡
- Efflux pump effects on Mycobacterium tuberculosis drug resistance. (2023/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Recurrent Regional Autonomic Dysfunction as a Presentation of Relapsing Neuromyelitis Optica Spectrum Disorder, Responsive to Ketamine Infusion. (2023/11/01) ♡
- Knowledge of Private Practitioners Regarding Revised National Tuberculosis Control Program- A Cross-Sectional Study from the Haryana state of India. (2023/10/21) ♡
- Determinants of quality of life among people with HIV and tuberculosis in an underserved area in Indonesia: a cross-sectional study. (2023/10/18) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. RETRACTED ARTICLE: Impact TB co-infections on immune tolerance among people living with HIV: a systematic review. (2023/10/17) ♡
- The Impact of the War in Ukraine on the Epidemiological Situation of Tuberculosis in Europe. (2023/10/16) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Visualization of pill in Extensively and totally drug resistant Mycobacterium Tuberculosis Using Light Microscopy. (2023/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A critical review of risk factors influencing the prevalence of extensive drug-resistant tuberculosis in India. (2023/10/01) ♡
- Evaluation of two colorimetric microplate microtiter tests for susceptibility testing of clinical isolates of Mycobacterium tuberculosis to first-line antituberculosis drugs. (2023/10/01) ♡
- Tuberculosis cases related to tertiary care cardiac center experiences in the last 10 years. (2023/10/01) ♡
- Identification of seven types of pili in Mycobacterium tuberculosis: Using atomic force microscopy. (2023/10/01) ♡
- The Profile of Multidrug Tuberculosis Regimen and Treatment Outcomes in Pulmonary MDR-TB Patients at the Tertiary Referral Hospital Dr. Soetomo, East Java, Indonesia: A Seven-Year Retrospective Study on Bedaquiline. (2023/10/01) ♡
- How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. (2023/09/25) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India. (2023/09/01) ♡
- Assessment of risk factors associated with multi-drug resistant tuberculosis (MDR-TB) in Gulu regional referral hospital. (2023/09/01) ♡
- What matters most? A qualitative study exploring priorities for supportive interventions for people with tuberculosis in urban Viet Nam. (2023/08/23) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Chest hemorrhage after left total pulmonary resection for secondary rifampin-resistant tuberculosis: a case report]. (2023/08/12) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.